Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Net Sales
2,115.07
1,852.61
1,945.23
1,199.94
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,115.07
1,852.61
1,945.23
1,199.94
0.00
Raw Material Cost
835.80
858.45
1,014.30
611.24
0.00
Purchase of Finished goods
176.63
182.22
280.82
162.92
0.00
(Increase) / Decrease In Stocks
64.22
-19.95
-125.36
-49.05
0.00
Employee Cost
161.96
138.41
129.69
85.20
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
412.10
307.43
303.74
182.68
0.00
Total Expenditure (Excl Depreciation)
1,650.71
1,466.56
1,603.19
992.99
0.00
Operating Profit (PBDIT) excl Other Income
464.36
386.05
342.04
206.95
0.00
Other Income
10.12
4.90
2.32
2.51
0.00
Operating Profit (PBDIT)
474.48
390.95
344.36
209.46
0.00
Interest
26.90
17.21
21.05
11.96
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
447.58
373.74
323.31
197.50
0.00
Depreciation
86.90
73.24
62.54
42.12
0.00
Profit Before Tax
360.69
300.49
260.77
155.38
0.00
Tax
88.28
83.59
67.28
33.13
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
272.40
216.90
193.49
122.25
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
272.40
216.90
193.49
122.25
0.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
272.40
216.90
193.49
122.25
0.00
Equity Capital
45.32
45.31
45.31
45.56
0.25
Face Value
5.0
5.0
5.0
10.0
10.0
Reserves
1,944.59
1,711.72
1,513.17
0.00
0.00
Earnings per share (EPS)
30.05
23.94
21.35
26.83
0.0
Diluted Earnings per share
30.04
23.93
21.35
13.49
-0.18
Operating Profit Margin (Excl OI)
21.95%
20.84%
17.58%
17.25%
0.0%
Gross Profit Margin
21.16%
20.17%
16.62%
16.46%
0.0%
PAT Margin
12.88%
11.71%
9.95%
10.19%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.17% vs -4.76% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 25.59% vs 12.10% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 20.28% vs 12.87% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 56.30% vs -18.24% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Aarti Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,115.07
1,286.41
828.66
64.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,115.07
1,286.41
828.66
64.42%
Raw Material Cost
835.80
350.81
484.99
138.25%
Purchase of Finished goods
176.63
21.95
154.68
704.69%
(Increase) / Decrease In Stocks
64.22
37.61
26.61
70.75%
Employee Cost
161.96
292.71
-130.75
-44.67%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
412.10
266.43
145.67
54.67%
Total Expenditure (Excl Depreciation)
1,650.71
969.51
681.20
70.26%
Operating Profit (PBDIT) excl Other Income
464.36
316.90
147.46
46.53%
Other Income
10.12
23.30
-13.18
-56.57%
Operating Profit (PBDIT)
474.48
340.20
134.28
39.47%
Interest
26.90
75.53
-48.63
-64.39%
Exceptional Items
0.00
-28.08
28.08
100.00%
Gross Profit (PBDT)
447.58
236.59
210.99
89.18%
Depreciation
86.90
112.99
-26.09
-23.09%
Profit Before Tax
360.69
123.60
237.09
191.82%
Tax
88.28
44.04
44.24
100.45%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
272.40
79.57
192.83
242.34%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
272.40
79.57
192.83
242.34%
Share in Profit of Associates
0.00
-1.27
1.27
100.00%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
272.40
78.29
194.11
247.94%
Equity Capital
45.32
9.78
35.54
363.39%
Face Value
5.00
1.00
0.00
Reserves
1,944.59
2,362.46
-417.87
-17.69%
Earnings per share (EPS)
30.05
4.00
26.05
651.25%
Diluted Earnings per share
30.04
4.02
26.02
647.26%
Operating Profit Margin (Excl OI)
21.95%
24.63%
0.00
-2.68%
Gross Profit Margin
21.16%
18.39%
0.00
2.77%
PAT Margin
12.88%
6.09%
0.00
6.79%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,115.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.17% vs -4.76% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 272.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.59% vs 12.10% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 464.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.28% vs 12.87% in Mar 2024
Annual - Interest
Interest 26.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 56.30% vs -18.24% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.95%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
